Quince Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -36 | -36 | -35 | |
EBITDA | -11,076 | -11,328 | -15,947 | |
EBIT | -11,112 | -11,364 | -15,982 | |
Net Income | 35,912 | -39,458 | -13,442 | -16,049 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,627 | -10,485 | -10,002 | -11,541 |
Cash | 18,163 | 5,809 | 6,452 | 16,826 |
Basic Shares | 5,009 | 5,572 | 5,395 | 4,668 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -142 | -186 | -322 | -175 |
EBITDA | -50,287 | -35,984 | -26,820 | -50,986 |
EBIT | -50,429 | -36,170 | -27,142 | -51,190 |
Net Income | -83,979 | -56,828 | -31,385 | -51,660 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,329 | |||
Free Cash Flow | -41,777 | -32,161 | -18,452 | -44,171 |
Cash | 5,809 | 6,212 | 20,752 | 44,579 |
Basic Shares | 5,009 | 4,326 | 3,723 | 3,349 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $2.88 |
2025-12-31 | -$0.40 |
2025-09-30 | -$0.25 |
2025-06-30 | -$0.34 |